Big Pharma

Bonne Idée worked with an international pharmaceutical leader on the design and facilitation of an advisory board bringing together leadership, product teams and medical experts from the Middle East. The objective was clear: gather field feedback after the launch of an innovative dermatological treatment, identify the barriers to adoption and jointly build the priorities for the rest of the rollout. A rich collaborative session, at the meeting point of clinical expertise and strategic vision.

Through a collective intelligence method built for the occasion, Bonne Idée turned a one-off advisory board into a genuine strategic tool. The approach made it possible to align decision-makers, take in the feedback of medical experts and prioritise the key actions to strengthen adoption of the product. Beyond the success of the session itself, the project shows Bonne Idée's ability to create high-value spaces for discussion, suited to joint problem-solving, agility and the continuous improvement of rollout programmes.